These antiviral proteins are produced by the body as a natural defense against viral infections and synthetic interferons might help prevent or treat the beginning stages of SARS-CoV-2 infection.

Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.

Rick Bright will no longer head the Biomedical Advanced Research and Development Authority and will instead work at the National Institutes of Health on diagnostics for SARS-CoV-2 infection.

Stay up-to-date on the progress of dozens of vaccine candidates that are currently undergoing clinical testing.

Strategies to trick, manipulate, and direct the evolution of tumors

Researchers are engineering microbes to deliver therapeutics specifically to tumors, maximizing the treatments’ efficacy while minimizing side effects.

Autonomous, living microrobots that seek and destroy cancer are not as futuristic as one might imagine, thanks to a fusion of robotics and synthetic biology.

New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.